<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352569</url>
  </required_header>
  <id_info>
    <org_study_id>DMDPT-TCH/MM/2015-A00842-47</org_study_id>
    <nct_id>NCT04352569</nct_id>
  </id_info>
  <brief_title>Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia</brief_title>
  <acronym>TDCSHALLU</acronym>
  <official_title>Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia: A Double Blind, Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de Ville-Evrard, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de Ville-Evrard, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Auditory hallucinations in schizophrenia are refractory to antipsychotics in 30% of patients.

      Non invasive brain stimulations technics like rTMS and tDCS are promising alternative tools
      to manage these symptoms.

      In this randomized double blind controlled to sham study the investigators will use tDCS to
      in 44 patients with refractory schizophrenic hallucinations.

      tDCS will be delivered twice a day during two weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2016</start_date>
  <completion_date type="Anticipated">December 12, 2020</completion_date>
  <primary_completion_date type="Actual">May 3, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>auditory hallucinations rating scale (AHRS)</measure>
    <time_frame>At baseline</time_frame>
    <description>AHRS is a scale frequently used to assess auditory hallucinations in schizophrenia studies (Hoffman et al. 2005).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>auditory hallucinations rating scale (AHRS)</measure>
    <time_frame>15 days after</time_frame>
    <description>AHRS is a scale frequently used to assess auditory hallucinations in schizophrenia studies (Hoffman et al. 2005).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PANSS,</measure>
    <time_frame>At baseline</time_frame>
    <description>Positive and negative symptom scale (PANSS, Kay et al. 1988)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PANSS,</measure>
    <time_frame>15 days after</time_frame>
    <description>Positive and negative symptom scale (PANSS, Kay et al. 1988)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CGI</measure>
    <time_frame>At baseline</time_frame>
    <description>clinical global impression (Kadouri et al. 2007)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CGI</measure>
    <time_frame>15 days after</time_frame>
    <description>clinical global impression (Kadouri et al. 2007)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Hallucinations</condition>
  <condition>Refractory Schizophrenia</condition>
  <arm_group>
    <arm_group_label>transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The transcranial direct current stimulation (tDCS) with two elecrodes placed over the scalp: the anode over the LTP, le cathode over L DLPFG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>transcranial direct current stimulation sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>tDCS device allows sham stimulation. This technic give the same impression that active stimulation and allows optimum placebo stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <description>transcranial direct current stimulation (tDCS) is a non invasive brain stimulation technic</description>
    <arm_group_label>transcranial direct current stimulation</arm_group_label>
    <arm_group_label>transcranial direct current stimulation sham</arm_group_label>
    <other_name>tDCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Schizophrenia according to DSM-V.

          -  Refractory auditory hallucinations(despite two antipsychotics trials).

          -  Right-handed patients.

          -  Written informed consent.

        Exclusion Criteria:

          -  Presence of other psychiatric disorders than schizophrenia (except addiction to
             tobacco or caffeine ).

          -  History of severe head trauma or coma.

          -  History of epilepsy or neurological disorder or a general medical condition.

          -  Presence of intracranial metallic objects or pacemaker.

          -  Hospitalized patients without consent.

          -  pregnant women .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NOOMANE BOUAZIZ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unité de Recherche Clinique de l'EPS de Ville Evard</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rusheenthira THAVASEELAN, Msc</last_name>
    <phone>0143093232</phone>
    <email>r.thavaseelan@epsve.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>NOOMANE BOUAZIZ, MD</last_name>
    <phone>0143093232</phone>
    <email>urcve1@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>unité de recherche clinique de l'E.P.S de Ville Evrard</name>
      <address>
        <city>Neuilly Sur Marne</city>
        <zip>93332</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rusheenthira THAVASEELAN, Msc</last_name>
      <phone>0143093232</phone>
      <email>r.thavaseelan@epsve.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre hospitalier de Ville-Evrard, France</investigator_affiliation>
    <investigator_full_name>Bouaziz</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hallucinations</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

